home / stock / tnxp / tnxp news


TNXP News and Press, Tonix Pharmaceuticals Holding Corp.

Stock Information

Company Name: Tonix Pharmaceuticals Holding Corp.
Stock Symbol: TNXP
Market: NASDAQ

Menu

TNXP TNXP Quote TNXP Short TNXP News TNXP Articles TNXP Message Board
Get TNXP Alerts

News, Short Squeeze, Breakout and More Instantly...

TNXP - How to Conduct Due Diligence on Penny Stocks, 3 Tips

3 Tips for Conducting Research With Penny Stocks Penny stocks are investments that require investors to conduct more due diligence prior to entering than with blue chips. Before investing in penny stocks , it’s important to understand the risks associated with penny stocks and do y...

TNXP - Why Is Reborn Coffee (REBN) Stock Up 34% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Evgeny Karandaev/ShutterStock.com Reborn Coffee (NASDAQ: REBN ) stock is heating up on Monday as investors take note of the California coffee company’s shares. With that comes heavy trading of REB...

TNXP - Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Harpoon Therapeutics (NASDAQ: HARP ) stock is taking off on Monday following the release of updated results from its myeloma drug candidate. HPN217 is the company’s...

TNXP - Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Today is a banner day for anyone who happened to hold Tonix Pharmaceuticals (NASDAQ: TNXP ) stock over the weekend. Early this morning, Tonix disclosed an exclusive license with a drug developer w...

TNXP - Tonix stock surges 20% on licensing deal for antibodies for COVID-19

Tonix Pharmaceuticals ( NASDAQ: TNXP ) said it obtained an exclusive license from Curia Global for developing three humanized murine monoclonal antibodies (mAbs) for treating or preventing SARS-CoV-2 infection. Tonix CEO Seth Lederman said that the transaction strengthens the...

TNXP - Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Humanized anti-SARS-CoV-2 Monoclonal Antibodies from Curia Global, Inc.

Immunocompromised Individuals, Including Organ Transplant Recipients, are at Increased Risk of Severe COVID-19 and Poor Clinical Outcomes SARS-CoV-2 has Mutated to Evade the Existing EUA-Approved Therapeutic Monoclonal Antibody Therapies CHATHAM, N.J., Dec. 12, 2022 (GLOBE NEWSWIR...

TNXP - Tonix Pharmaceuticals Announces Collaboration with Boston Children's Hospital to Study TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Graft-versus-Host Disease (GvHD) Following Hematopoietic Stem Cell Transplantation in Animals

Hematopoietic Stem Cell Transplantation (HCT) from Unrelated Donors is a Component of the Treatment Protocol for Several Hematologic Malignancies GvHD Complicates Treatment and Limits the Success of Engraftment after HCT In addition to GvHD, Tonix is Developing TNX-1500 for Prop...

TNXP - Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress

TNX-801 is Based on the Sequence of a Natural Isolate of Horsepox and is Believed Closer in Structure to Edward Jenner’s 1798 Vaccine than Modern Vaccinia Virus Vaccines Against Smallpox Live-Virus Vaccine Platform Leverages Tonix’s Expanding Internal Development and Manuf...

TNXP - Tonix Pharmaceuticals Announced Data from its Fully Human anti-SARS-CoV-2 Monoclonal Antibody Platform in an Oral Presentation at the World Antiviral Congress

Research Being Conducted in Collaboration with Scientists at Columbia University SARS-CoV-2 Variants have Evaded Antibody Therapeutics Previously Granted FDA Emergency Use Authorization, but which are No Longer Recommended for Use by the NIH COVID-19 Guidelines Panel Immunocompr...

TNXP - Tonix Pharmaceuticals to Participate in the A.G.P. Biotech Conference

CHATHAM, N.J., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that management will participate virtually in the A.G.P. Biotech Conference and host investor meetings. The conference is being he...

Next 10